HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Disease severity and thin filament regulation in M9R TPM3 nemaline myopathy.

Abstract
The mechanism of muscle weakness was investigated in an Australian family with an M9R mutation in TPM3 (alpha-tropomyosin(slow)). Detailed protein analyses of 5 muscle samples from 2 patients showed that nemaline bodies are restricted to atrophied Type 1 (slow) fibers in which the TPM3 gene is expressed. Developmental expression studies showed that alpha-tropomyosin(slow) is not expressed at significant levels until after birth, thereby likely explaining the childhood (rather than congenital) disease onset in TPM3 nemaline myopathy. Isoelectric focusing demonstrated that alpha-tropomyosin(slow) dimers, composed of equal ratios of wild-type and M9R-alpha-tropomyosin(slow), are the dominant tropomyosin species in 3 separate muscle groups from an affected patient. These findings suggest that myopathy-related slow fiber predominance likely contributes to the severity of weakness in TPM3 nemaline myopathy because of increased proportions of fibers that express the mutant protein. Using recombinant proteins and far Western blot, we demonstrated a higher affinity of tropomodulin for alpha-tropomyosin(slow) compared with beta-tropomyosin; the M9R substitution within alpha-tropomyosin(slow) greatly reduced this interaction. Finally, transfection of the M9R mutated and wild-type alpha-tropomyosin(slow) into myoblasts revealed reduced incorporation into stress fibers and disruption of the filamentous actin network by the mutant protein. Collectively, these results provide insights into the clinical features and pathogenesis of M9R-TPM3 nemaline myopathy.
AuthorsBiljana Ilkovski, Nancy Mokbel, Raymond A Lewis, Kendall Walker, Kristen J Nowak, Ana Domazetovska, Nigel G Laing, Velia M Fowler, Kathryn N North, Sandra T Cooper
JournalJournal of neuropathology and experimental neurology (J Neuropathol Exp Neurol) Vol. 67 Issue 9 Pg. 867-77 (Sep 2008) ISSN: 0022-3069 [Print] England
PMID18716557 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Protein Isoforms
  • TPM3 protein, human
  • Tropomodulin
  • Tropomyosin
Topics
  • Adult
  • Blotting, Western
  • Child, Preschool
  • Female
  • Fetus
  • Humans
  • Immunohistochemistry
  • Infant
  • Infant, Newborn
  • Isoelectric Focusing
  • Middle Aged
  • Muscle Fibers, Slow-Twitch (pathology)
  • Muscle, Skeletal (pathology)
  • Mutation
  • Myopathies, Nemaline (genetics, metabolism, pathology)
  • Protein Isoforms (genetics, metabolism)
  • Tropomodulin (metabolism)
  • Tropomyosin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: